![Øystein Soug](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Øystein Soug
Amministratore Delegato presso Arxx Therapeutics AS
Posizioni attive di Øystein Soug
Società | Posizione | Inizio | Fine |
---|---|---|---|
Pharmasum Therapeutics AS
![]() Pharmasum Therapeutics AS BiotechnologyHealth Technology Pharmasum Therapeutics AS operates as a pharmaceutical company. The firm focuses on the discovery and development of novel human medicines for the treatment of brain diseases, especially neurological diseases. The company was founded by Anders Fugelli and John Sigurd Svendsen is headquartered in Kvaloysletta, Norway. | Direttore/Membro del Consiglio | - | - |
Arxx Therapeutics AS
![]() Arxx Therapeutics AS BiotechnologyHealth Technology Arxx Therapeutics AS develops therapeutics for fibrotic diseases. The company is based in Oslo, Norway. The Norwegian company was founded in 2015 by Jonas Hallén, Jörg Klingelhöfer. Øystein Soug has been the CEO of the company since 2022. | Amministratore Delegato | 01/01/2022 | - |
Storia della carriera di Øystein Soug
Precedenti posizioni note di Øystein Soug
Società | Posizione | Inizio | Fine |
---|---|---|---|
CIRCIO HOLDING ASA | Amministratore Delegato | 02/11/2016 | 20/10/2021 |
Direttore Finanziario/CFO | 20/10/2021 | 07/03/2022 | |
Contatto Relazioni con gli Investitori | 01/05/2015 | 20/10/2021 | |
ORKLA ASA | Direttore Finanziario/CFO | - | - |
Bionor Pharma ASA
![]() Bionor Pharma ASA Pharmaceuticals: OtherHealth Technology Bionor Pharma ASA engages in research and development, patenting, and commercialization of products in the pharmaceuticals and biotech industry. The company focuses on the research and development of peptide-based vaccines against viral diseases, primarily HIV. The company was founded on January 2, 1993 and is headquartered in Oslo, Norway. | Direttore/Membro del Consiglio | 15/05/2013 | - |
ALGETA ASA | Direttore Amministrativo | 13/08/2008 | 04/03/2013 |
Direttore Finanziario/CFO | 13/08/2008 | - | |
Contatto Relazioni con gli Investitori | 13/08/2008 | 04/03/2013 | |
Public Communications Contact | 13/08/2008 | 04/03/2013 |
Formazione di Øystein Soug
University of St. Gallen | Graduate Degree |
Statistiche
Distribuzione geografica
Norvegia | 7 |
Svizzera | 2 |
Posizioni
Director of Finance/CFO | 3 |
Investor Relations Contact | 2 |
Director/Board Member | 2 |
Settori
Health Technology | 6 |
Consumer Services | 2 |
Consumer Non-Durables | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 2 |
---|---|
CIRCIO HOLDING ASA | Health Technology |
ORKLA ASA | Consumer Non-Durables |
Aziende private | 4 |
---|---|
Algeta ASA
![]() Algeta ASA Pharmaceuticals: MajorHealth Technology Algeta ASA is engaged in the development of products for the treatment of cancer. The company focuses on the development of anti-cancer drugs, and its research and development of compounds focuses on the various applications of a few base compounds. Its products, Alpharadin and Thorium-227, are being developed for treatment of skeletal metastases originating from prostate and breast cancer. The company was founded by Roy H. Larsen and Øyvind Sverre Bruland in 1997 and is headquartered in Oslo, Norway. | Health Technology |
Bionor Pharma ASA
![]() Bionor Pharma ASA Pharmaceuticals: OtherHealth Technology Bionor Pharma ASA engages in research and development, patenting, and commercialization of products in the pharmaceuticals and biotech industry. The company focuses on the research and development of peptide-based vaccines against viral diseases, primarily HIV. The company was founded on January 2, 1993 and is headquartered in Oslo, Norway. | Health Technology |
Pharmasum Therapeutics AS
![]() Pharmasum Therapeutics AS BiotechnologyHealth Technology Pharmasum Therapeutics AS operates as a pharmaceutical company. The firm focuses on the discovery and development of novel human medicines for the treatment of brain diseases, especially neurological diseases. The company was founded by Anders Fugelli and John Sigurd Svendsen is headquartered in Kvaloysletta, Norway. | Health Technology |
Arxx Therapeutics AS
![]() Arxx Therapeutics AS BiotechnologyHealth Technology Arxx Therapeutics AS develops therapeutics for fibrotic diseases. The company is based in Oslo, Norway. The Norwegian company was founded in 2015 by Jonas Hallén, Jörg Klingelhöfer. Øystein Soug has been the CEO of the company since 2022. | Health Technology |
- Borsa valori
- Insiders
- Øystein Soug
- Esperienza